Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1
Frontiers | Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Nature Biotechnology
Frontiers | Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy: Trends in Immunology
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment | npj Precision Oncology
Imaging of tumour response to immunotherapy | European Radiology Experimental | Full Text
Current issues and perspectives in PD-1 blockade cancer immunotherapy | SpringerLink
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy | Nature Reviews Cancer
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients - Clinical Lung Cancer
Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - Rezasoltani - 2021 - Cancer Medicine - Wiley Online Library
Early Screening of Pancreatic Cancer Immunotherapy Target Candidates | Technology Networks
Epitope spreading is spreading success in immunotherapy
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | ResearchGate
Immunotherapy and targeted therapy combinations in metastatic breast cancer - The Lancet Oncology
The future of cancer immunotherapy: microenvironment-targeting combinations | Cell Research
Immunotherapy for cancer: How it works, who's a candidate, and where to get it | CTCA
Profiling of immune features to predict immunotherapy efficacy
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect
Making immunotherapy more effective against small cell lung cancer
